Recon: Sanofi to acquire Blueprint in $9B deal; FDA approves Moderna’s next-gen COVID vaccine for older adults
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States